Testing Treatment for Prostate Cancer
common.study.values.description
“Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer”
The purpose of this study is to evaluate the dose of High Dose Rate (HDR) brachytherapy chosen for this study as well as a commonly used alternate form of brachytherapy called low dose rate (or seed) brachytherapy. Investigators would like to understand how these treatments control the prostate cancer and look at their short and long term treatment related side effects.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Radiation - Low dose rate brachytherapy
I-125 to a total dose of 144 Gy
Radiation - High dose rate brachytherapy
19 Gy in 1 fraction plus intraprostatic boost to GTV
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Randomized Phase II Trial Evaluating Hight Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
common.study.values.clinical-trial-id
NCT02960087
participant.views.study.view.id
nelmga
